Skip to main content
. 2022 Dec 1;22:889. doi: 10.1186/s12884-022-05219-4

Table 1.

Clinical characteristics and laboratory biomarkers among the basic population

Variable Training cohort
(n = 2026)
Validation cohort
(n = 869)
p
Age (year) 30.0 (27.0–32.0) 30.0 (27.0–32.0) 0.753
Nulliparous, n (%) 0.443
 No 1254 (61.9) 524 (39.7)
 Yes 772 (38.1) 345 (60.3)
History of GDM, n (%) 0.276
 No 1934 (95.5) 838 (96.4)
 Yes 92 (4.5) 31 (3.6)
History of macrosomia, n (%) 0.099
 No 1992 (98.3) 862 (99.2)
 Yes 34 (1.7) 7 (0.8)
History of abnormal pregnancy, n (%) 0.474
 No 1943 (95.9) 828 (95.3)
 Yes 83 (4.1) 41 (4.7)
Family history of DM, n (%) 0.709
 No 2000 (98.7) 860 (99.0)
 Yes 26 (1.3) 9 (1.0)
PCOS, n (%) 0.911
 No 2000 (98.7) 859 (98.8)
 Yes 26 (1.3) 10 (1.2)
Pre–pregnancy BMI (kg/m2) 20.6 (18.9–22.7) 20.5 (18.9–22.6) 0.875
WBC (109/L) 8.9 (7.6–10.4) 8.8 (7.7–10.1) 0.420
NEUT (%) 72.3 (68.1–75.9) 72.1 (68.1–76.0) 0.881
RBC (1012/L) 4.0 (3.8–4.3) 4.1 (3.8–4.3) 0.316
HGB (g/L) 120.5 (114.0–127.0) 120.4 (114.0–128.0) 0.872
HCT (%) 36.0 (34.0–37.9) 36.0 (34.0–38.0) 0.457
PLT (109/L) 241.5 (207.7–278.7) 238.5 (205.6–273.0) 0.277
MPV (fL) 9.6 (8.6–10.4) 9.5 (8.6–10.4) 0.977
ALT (U/L) 12.1 (9.2–18.0) 12.0 (9.5–17.0) 0.591
AST (U/L) 16.0 (13.5–19.0) 16.0 (13.6–18.4) 0.494
Creatinine (μmol/L) 45.7 (41.0–51.0) 46.0 (41.2–51.4) 0.283
Uric acid (μmol/L) 239.0 (202.5–278.2) 233.0 (203.0–270.0) 0.202
FBG (mmol/L) 4.5 (4.2–4.9) 4.5 (4.3–4.9) 0.405

Abbreviations: GDM Gestational diabetes mellitus, DM Diabetes mellitus, PCOS Polycystic ovary syndrome, BMI Body mass index, WBC White blood cell count, NEUT Neutrophil percentage, RBC Red blood cell count, HGB Hemoglobin, HCT Hematocrit, PLT Platelet count, MPV Mean platelet volume, ALT Alanine aminotransferase, AST Aspartate aminotransferase, FBG Fasting blood glucose